11-methoxy-3,9-dimethyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide

ID: ALA273149

PubChem CID: 16759937

Max Phase: Preclinical

Molecular Formula: C18H16N2O3S

Molecular Weight: 340.40

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2ccc(C)nc2c2c1-c1cc(C)ccc1S(=O)(=O)N2

Standard InChI:  InChI=1S/C18H16N2O3S/c1-10-4-7-15-13(8-10)16-14(23-3)9-12-6-5-11(2)19-17(12)18(16)20-24(15,21)22/h4-9,20H,1-3H3

Standard InChI Key:  UXHUBTDSTIIYHF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -4.6339  -18.3161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6339  -19.1433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9215  -19.5546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9215  -17.9002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2045  -18.3161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2081  -19.1433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4975  -19.5575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7787  -19.1493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4904  -17.9033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7778  -18.3236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7643  -16.6718    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4868  -17.0783    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0516  -17.0921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0647  -17.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3596  -18.3407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3633  -17.9412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3764  -17.1148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3333  -16.6879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0684  -18.3648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3619  -15.9580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1844  -15.9580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3472  -17.9066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680  -19.5636    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0714  -20.3860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9 12  1  0
 10 14  1  0
 13 11  1  0
 11 12  1  0
 13 14  1  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  5  9  2  0
  6  7  2  0
  7  8  1  0
 13 18  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
  8 10  2  0
 16 19  1  0
  9 10  1  0
 11 20  2  0
  3  6  1  0
 11 21  2  0
  5  4  1  0
  1 22  1  0
  5  6  1  0
  8 23  1  0
 23 24  1  0
M  END

Associated Targets(Human)

NFKBIA Tchem NF-kappaB inhibitor alpha (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RELA Tchem Nuclear factor NF-kappa-B p65 subunit (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 340.40Molecular Weight (Monoisotopic): 340.0882AlogP: 3.64#Rotatable Bonds: 1
Polar Surface Area: 68.29Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 6.51CX Basic pKa: 4.20CX LogP: 2.78CX LogD: 2.11
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.73Np Likeness Score: -0.70

References

1. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS..  (2008)  Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.,  18  (1): [PMID:18024113] [10.1016/j.bmcl.2007.10.100]
2. Tsai KC, Teng LW, Shao YM, Chen YC, Lee YC, Li M, Hsiao NW..  (2009)  The first pharmacophore model for potent NF-kappaB inhibitors.,  19  (19): [PMID:19726185] [10.1016/j.bmcl.2009.08.021]

Source